Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
BioNexus Gene Lab Corp
| Metric | BioNexus Gene Lab Corp BGLCOther |
|---|---|
| Quality Score | 40 / 100 |
| Revenue (latest) | $7M |
| Net income (latest) | −$3M |
| Operating margin | −39.9% |
| Net margin | −40.2% |
| Return on equity | −34.6% |
| Return on assets | −32.3% |
| Return on capital (ROCE) | −34.0% |
| Debt / equity | 0.07× |
| Revenue growth (YoY) | −21.9% |
| Altman Z″ (distress) | 13.26 |
| Accruals / assets | −12.4% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.